Inhibition of transient receptor potential vanilloid 1 (TRPV1) channel regulates chikungunya virus infection in macrophages
- PMID: 33125586
- DOI: 10.1007/s00705-020-04852-8
Inhibition of transient receptor potential vanilloid 1 (TRPV1) channel regulates chikungunya virus infection in macrophages
Abstract
Chikungunya virus (CHIKV), a virus that induces pathogenic inflammatory host immune responses, is re-emerging worldwide, and there are currently no established antiviral control measures. Transient receptor potential vanilloid 1 (TRPV1), a non-selective Ca2+-permeable ion channel, has been found to regulate various host inflammatory responses including several viral infections. Immune responses to CHIKV infection in host macrophages have been reported recently. However, the possible involvement of TRPV1 during CHIKV infection in host macrophages has not been studied. Here, we investigated the possible role of TRPV1 in CHIKV infection of the macrophage cell line RAW 264.7. It was found that CHIKV infection upregulates TRPV1 expression in macrophages. To confirm this observation, the TRPV1-specific modulators 5'-iodoresiniferatoxin (5'-IRTX, a TRPV1 antagonist) and resiniferatoxin (RTX, a TRPV1 agonist) were used. Our results indicated that TRPV1 inhibition leads to a reduction in CHIKV infection, whereas TRPV1 activation significantly enhances CHIKV infection. Using a plaque assay and a time-of-addition assay, it was observed that functional modulation of TRPV1 affects the early stages of the viral lifecycle in RAW 264.7 cells. Moreover, CHIKV infection was found to induce of pNF-κB (p65) expression and nuclear localization. However, both activation and inhibition of TRPV1 were found to enhance the expression and nuclear localization of pNF-κB (p65) and production of pro-inflammatory TNF and IL-6 during CHIKV infection. In addition, it was demonstrated by Ca2+ imaging that TRPV1 regulates Ca2+ influx during CHIKV infection. Hence, the current findings highlight a potentially important regulatory role of TRPV1 during CHIKV infection in macrophages. This study might also have broad implications in the context of other viral infections as well.
Similar articles
-
P38 and JNK Mitogen-Activated Protein Kinases Interact With Chikungunya Virus Non-structural Protein-2 and Regulate TNF Induction During Viral Infection in Macrophages.Front Immunol. 2019 Apr 12;10:786. doi: 10.3389/fimmu.2019.00786. eCollection 2019. Front Immunol. 2019. PMID: 31031770 Free PMC article.
-
Activity of andrographolide against chikungunya virus infection.Sci Rep. 2015 Sep 18;5:14179. doi: 10.1038/srep14179. Sci Rep. 2015. PMID: 26384169 Free PMC article.
-
TLR4 is one of the receptors for Chikungunya virus envelope protein E2 and regulates virus induced pro-inflammatory responses in host macrophages.Front Immunol. 2023 Apr 20;14:1139808. doi: 10.3389/fimmu.2023.1139808. eCollection 2023. Front Immunol. 2023. PMID: 37153546 Free PMC article.
-
Current Strategies for Inhibition of Chikungunya Infection.Viruses. 2018 May 3;10(5):235. doi: 10.3390/v10050235. Viruses. 2018. PMID: 29751486 Free PMC article. Review.
-
Antiviral therapeutics for chikungunya virus.Expert Opin Ther Pat. 2020 Jun;30(6):467-480. doi: 10.1080/13543776.2020.1751817. Epub 2020 Apr 17. Expert Opin Ther Pat. 2020. PMID: 32249636 Review.
Cited by
-
Clinical, Virological, Immunological, and Genomic Characterization of Asymptomatic and Symptomatic Cases With SARS-CoV-2 Infection in India.Front Cell Infect Microbiol. 2021 Dec 21;11:725035. doi: 10.3389/fcimb.2021.725035. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 34993157 Free PMC article.
-
A Comprehensive Molecular and Clinical Investigation of Approved Anti-HCV Drugs Repurposing against SARS-CoV-2 Infection: A Glaring Gap between Benchside and Bedside Medicine.Vaccines (Basel). 2023 Feb 22;11(3):515. doi: 10.3390/vaccines11030515. Vaccines (Basel). 2023. PMID: 36992099 Free PMC article.
-
Acidic Microenvironments Found in Cutaneous Leishmania Lesions Curtail NO-Dependent Antiparasitic Macrophage Activity.Front Immunol. 2022 Apr 14;13:789366. doi: 10.3389/fimmu.2022.789366. eCollection 2022. Front Immunol. 2022. PMID: 35493523 Free PMC article.
-
Carcinogenesis and Metastasis: Focus on TRPV1-Positive Neurons and Immune Cells.Biomolecules. 2023 Jun 13;13(6):983. doi: 10.3390/biom13060983. Biomolecules. 2023. PMID: 37371563 Free PMC article. Review.
-
Salicylic Acid Conjugate of Telmisartan Inhibits Chikungunya Virus Infection and Inflammation.ACS Omega. 2023 Dec 21;9(1):146-156. doi: 10.1021/acsomega.3c00763. eCollection 2024 Jan 9. ACS Omega. 2023. PMID: 38222605 Free PMC article.
References
-
- Tominaga M, Tominaga T (2005) Structure and function of TRPV1. Pflugers Arch 451:143–150. https://doi.org/10.1007/s00424-005-1457-8 - DOI - PubMed
-
- Ortíz-Rentería M, Juárez-Contreras R, González-Ramírez R et al (2018) TRPV1 channels and the progesterone receptor Sig-1R interact to regulate pain. Proc Natl Acad Sci. https://doi.org/10.1073/pnas.1715972115 - DOI - PubMed
-
- Choi JY, Lee HY, Hur J et al (2018) TRPV1 blocking alleviates airway inflammation and remodeling in a chronic asthma murine model. Allergy Asthma Immunol Res 10:216–224. https://doi.org/10.4168/aair.2018.10.3.216 - DOI - PubMed - PMC
-
- Majhi RK, Sahoo SS, Yadav M et al (2015) Functional expression of TRPV channels in T cells and their implications in immune regulation. FEBS J 282:2661–2681. https://doi.org/10.1111/febs.13306 - DOI - PubMed
-
- Yang F, Ma L, Cao X et al (2014) Divalent cations activate TRPV1 through promoting conformational change of the extracellular region. J General Physiol 143:91–103. https://doi.org/10.1085/jgp.201311024 - DOI
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous